99-2097. Notice Pursuant to the National Cooperative Research and Production Act of 1993; Inter Company Collaboration for AIDS Drug Development

[Federal Register Volume 64, Number 19 (Friday, January 29, 1999)]
[Notices]
[Page 4707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2097]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993; Inter Company Collaboration for AIDS Drug 
Development

    Notice is hereby given that, on November 30, 1998, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Inter Company Collaboration 
for AIDS Drug Development has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership and project status. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Bayer AG has been 
dropped as a party to this venture. Also, the members of the 
Collaboration have decided to extend the Collaboration for a five year 
period, up to and including December 31, 2003. The Collaboration will 
continue the activities in which it has been engaged since its initial 
formation, including new activities added after its founding, as 
described in its initial and subsequent filings. In addition, the 
members have decided to extend the activities of the Collaboration to 
include activities involving substances that may enhance the immune 
function in HIV-infected individuals.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Inter Company Collaboration for AIDS 
Drug Development intends to file additional written notification 
disclosing all changes in membership.
    On May 27, 1993, Inter Company Collaboration for AIDS Drug 
Development filed its original notification pursuant to Section 6(a) of 
the Act. The Department of Justice published a notice in the Federal 
Register pursuant to Section 6(b) of the Act on July 6, 1993 (58 FR 
36223).
    The last notification was filed with the Department on July 13, 
1998. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on September 29, 1998 (63 FR 51955).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 99-2097 Filed 1-28-99; 8:45 am]
BILLING CODE 4410-11-M